Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL698912

COc1cc2nccc(Oc3ccc(NC(=O)c4cc(C)n(C(C)(C)C)n4)cc3F)c2cc1OC.O=C(O)C(F)(F)F

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 12/20 0.59
AXL P30530 13/20 0.59
MST1R Q04912 2/20 0.58
AURKA O14965 2/20 0.56
ABL1 P00519 2/20 0.56
LCK P06239 2/20 0.56
SRC P12931 2/20 0.56
AURKB Q96GD4 2/20 0.56
FER P16591 1/20 0.56
CDK8 P49336 1/20 0.56
TYRO3 Q06418 1/20 0.56
MERTK Q12866 1/20 0.56
MAP2K5 Q13163 1/20 0.56
KDR P35968 2/20 0.56
JAK2 O60674 1/20 0.56
RPS6KA5 O75582 1/20 0.56
INSR P06213 1/20 0.56
RET P07949 1/20 0.56
IGF1R P08069 1/20 0.56
KIT P10721 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL168502 0.96 MET (0.61) METAXLMST1RAURKAABL1
Trifluoroacetic Acid SCHEMBL168241 0.91 AXL (0.66) METAXLMST1RAURKAABL1
SCHEMBL167638 0.85 AXL (0.69) METAXLMST1RAURKAABL1
SCHEMBL168721 0.85 MET (0.62) METAXLKDRKITFLT3
Trifluoroacetic Acid SCHEMBL705178 0.85 AXL (0.64) METAXLMST1RAURKAABL1
SCHEMBL168132 0.84 MET (0.71) METAXLMST1RAURKAABL1
Trifluoroacetic Acid SCHEMBL698181 0.84 MET (0.63) METAXLMST1RAURKAABL1
Trifluoroacetic Acid SCHEMBL696273 0.83 AXL (0.58) METAXLMST1RAURKAABL1
Trifluoroacetic Acid SCHEMBL167604 0.81 AXL (0.64) METAXLMST1RAURKAABL1
Trifluoroacetic Acid SCHEMBL696882 0.80 AXL (0.64) METAXLMST1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609091-B1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2014-11-26 EP disclosed
EP-2423208-A1 Pharmaceutically active compounds as Axl inhibitors Lead Discovery Center GmbH (DE) 2012-02-29 EP disclosed